Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B

May 12, 2026 05:06 AM EDT DealsChinaPharma Bris­tol My­ers joins Hen­grui par­ty in 13-as­set deal worth up to $15.2B Kyle LaHucik Biotech Correspondent It’s be­com­ing Hen­grui Phar­ma’s world, and some West­ern drug­mak­ers are just liv­ing in it. Chi­na’s largest phar­ma com­pa­ny, which boasts one of the biggest pipelines … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER